Biolife Sciences (Biolife Sciences) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Biolife Sciences's net issuance of preferred for the three months ended in May. 2008 was $0.00 Mil. The number is 0, which means that Biolife Sciences has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Biolife Sciences's net issuance of preferred for the trailing twelve months (TTM) ended in May. 2008 was $0.00 Mil.

Biolife Sciences Net Issuance of Preferred Stock Historical Data

The historical data trend for Biolife Sciences's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Net Issuance of Preferred Stock Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Net Issuance of Preferred Stock

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Net Issuance of Preferred Stock	Get a 7-Day Free Trial										-	-	-	-	-

Biolife Sciences Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Biolife Sciences Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020